Current Vascular Pharmacology
Title:Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality
Volume: 16 Issue: 3
Author(s): Vasilios G. Athyros and Michael Doumas
Affiliation:
Export Options
About this article
Cite this article as:
Athyros G. Vasilios and Doumas Michael , Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality, Current Vascular Pharmacology 2018; 16 (3) . https://dx.doi.org/10.2174/157016111603180326112541
DOI https://dx.doi.org/10.2174/157016111603180326112541 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Stress Echocardiography
Current Pharmaceutical Design Pharmacological Prevention and Treatment in Clinical At-Risk States for Psychosis
Current Pharmaceutical Design Titin and Troponin: Central Players in the Frank-Starling Mechanism of the Heart
Current Cardiology Reviews Review of the Pharmacology of the Emerging Possibilities of the Direct Oral Anticoagulants' Reversal
Current Drug Metabolism Neurosteroids and Sporadic Alzheimers Disease
Current Alzheimer Research Non-Invasive Methods and Techniques for Central Blood Pressure Estimation: Procedures, Validation, Reproducibility and Limitations
Current Pharmaceutical Design Vitamins in Heart Failure: Friend or Enemy?
Current Pharmaceutical Design Thyroid Disorders in Chronic Heart Failure: From Prognostic Set-up to Therapeutic Management
Endocrine, Metabolic & Immune Disorders - Drug Targets Calcium Pumps of Plasma Membrane and Cell Interior
Current Molecular Medicine The Antitumor Effects of Icaritin Against Breast Cancer is Related to Estrogen Receptors
Current Molecular Medicine Optimizing the Management of Uncontrolled/Resistant Hypertension. The Importance of Sleep Apnoea Syndrome
Current Vascular Pharmacology The Metabolism of Methazolamide in Immortalized Human Keratinocytes, HaCaT Cells
Drug Metabolism Letters Pharmacotherapy for the Metabolic Syndrome
Current Vascular Pharmacology Catalpol: A Potential Therapeutic for Neurodegenerative Diseases
Current Medicinal Chemistry Recommendations for Severe Hypertriglyceridemia Treatment, are there New Strategies?
Current Vascular Pharmacology Interaction Between Genetic Polymorphisms in Renin-Angiotensin System (RAS) and Therapeutic Efficacy of RAS Blockade in IgA Nephropathy
Current Pharmacogenomics Clinical Significance of the Blood Pressure Changes from Day to Night
Current Hypertension Reviews Schizophrenia and the Neglect Syndrome: Parietal Contributions to Cognitive Dysfunction in Schizophrenia
Current Psychiatry Reviews Meet Our Editorial Board Members:
Current Genomics Update on Statins: Hope for Osteoporotic Fracture Healing Treatment
Current Drug Targets